- Pieris Pharmaceuticals (NASDAQ:PIRS) Q3 results: Revenues: $8.3M (+112.8%).
- Net Loss: ($6.2M) (+12.7%); Loss Per Share: ($0.11) (+31.3%); Quick Assets: $137.3M (+89.1%).
- Previously: Pieris Pharmaceuticals beats by $0.01, beats on revenue (Nov. 7)
Pieris Pharmaceuticals Q3 revenues up 113%
Recommended For You
More Trending News
About PIRS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PIRS | - | - |
Pieris Pharmaceuticals, Inc. |